Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiying Qiu

Showing results (71-80 of 194) with videos related to

Pageof 20
Sort By:
Cancer Genetics|April 5, 2014
The characteristics and prognostic analysis in 213 myeloid malignancy patients with del(20q): a report of a single-center case seriesJinlan Pan, Chunxiao Wu, Yongquan Xue, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 11, 2014
[Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia]Zhen Cheng, Lan Zhao, Guanghua Chen, et al.
Journal of Cellular Physiology|October 30, 2018
Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59Hui Cheng, Li Chen, Xiaoxia Hu, et al.
Leukemia & Lymphoma|April 6, 2019
Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemiaMingzhu Xu, Hong Liu, Yuejun Liu, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 30, 2024
Risk Factors for Subclinical Diabetic Peripheral Neuropathy in Type 2 Diabetes MellitusLi Gao, Jiexing Qin, Ying Chen, et al.
British Journal of Haematology|July 15, 2026
Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II studyJie Gao, Huiying Qiu, Yin Tong, et al.
Frontiers in Oncology|October 14, 2021
Development of a Nomogram for Predicting the Cumulative Incidence of Disease Recurrence of AML After Allo-HSCTTongtong Zhang, Xiebing Bao, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 27, 2014
[A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes]Xiaomin Gui, Jinlan Pan, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 11, 2014
[Outcomes of imatinib and allogeneic hematopoietic stem cell transplantation in the treatment of chronic myeloid leukemia]Min Zhou, Xinshan Sha, Huiying Qiu, et al.
Hematology (Amsterdam, Netherlands)|April 12, 2021
Allogeneic hematopoietic stem cell transplantation could improve the survival of acute myeloid leukemia patients with ASXL1 mutationsLili Zhou, Jingnan An, Chang Hou, et al.
Pageof 20

Showing results (71-80 of 194) with videos related to

Sort By:
Pageof 20
Cancer Genetics|April 5, 2014
The characteristics and prognostic analysis in 213 myeloid malignancy patients with del(20q): a report of a single-center case seriesJinlan Pan, Chunxiao Wu, Yongquan Xue, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 11, 2014
[Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia]Zhen Cheng, Lan Zhao, Guanghua Chen, et al.
Journal of Cellular Physiology|October 30, 2018
Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59Hui Cheng, Li Chen, Xiaoxia Hu, et al.
Leukemia & Lymphoma|April 6, 2019
Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemiaMingzhu Xu, Hong Liu, Yuejun Liu, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 30, 2024
Risk Factors for Subclinical Diabetic Peripheral Neuropathy in Type 2 Diabetes MellitusLi Gao, Jiexing Qin, Ying Chen, et al.
British Journal of Haematology|July 15, 2026
Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II studyJie Gao, Huiying Qiu, Yin Tong, et al.
Frontiers in Oncology|October 14, 2021
Development of a Nomogram for Predicting the Cumulative Incidence of Disease Recurrence of AML After Allo-HSCTTongtong Zhang, Xiebing Bao, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 27, 2014
[A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes]Xiaomin Gui, Jinlan Pan, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 11, 2014
[Outcomes of imatinib and allogeneic hematopoietic stem cell transplantation in the treatment of chronic myeloid leukemia]Min Zhou, Xinshan Sha, Huiying Qiu, et al.
Hematology (Amsterdam, Netherlands)|April 12, 2021
Allogeneic hematopoietic stem cell transplantation could improve the survival of acute myeloid leukemia patients with ASXL1 mutationsLili Zhou, Jingnan An, Chang Hou, et al.
Pageof 20